Research by a team of British researchers has found that the Kovid anti-booster vaccine controls about 85% of all cases of omicarone infection.
The researchers say that this booster vaccine significantly reduces the risk of hospitalization for omicchronone infections.
More than 93,000 cases were reported in Britain yesterday (Jan. 17) as the new strain is spreading rapidly, they said.